Retatrutide Research Peptide
Retatrutide is an investigational triple-agonist peptide studied for simultaneous activity at the GLP-1, GIP, and glucagon receptors. This page covers what the preclinical literature describes and what our lots ship with.
Updated August 8, 2026
Mechanism studied in the literature
Where semaglutide targets GLP-1 alone and tirzepatide adds GIP, retatrutide is described as engaging a third receptor: glucagon. Preclinical work attributes its distinct metabolic profile to that third arm, which is associated with energy expenditure rather than intake signaling alone.
Because all three receptor arms are active at once, retatrutide is a common comparator in receptor-selectivity and metabolic-signaling studies rather than a drop-in substitute for single-agonist compounds.
What ships with each lot
- Third-party HPLC purity chromatogram for the specific lot
- Mass spectrometry identity confirmation
- Batch number printed on the vial and recorded in your order
- Lyophilized presentation with insulated domestic shipping
Related reading
We maintain a plain-language explainer covering the compound's background and a separate summary of preclinical tumor-volume findings in murine models. Both are research summaries, not treatment claims.
All compounds are sold strictly for laboratory research and development. They are not for human or veterinary use, and nothing on this page is medical advice.
Frequently asked questions
- What is retatrutide?
- An investigational research peptide described in the literature as a triple agonist at the GLP-1, GIP, and glucagon receptors. It is studied preclinically and is not approved for human use.
- How does retatrutide differ from tirzepatide?
- Tirzepatide is a dual GLP-1 / GIP agonist. Retatrutide adds glucagon receptor activity as a third arm, which is the focus of much of the comparative preclinical work.
- How should retatrutide be stored?
- Lyophilized material is typically kept frozen or refrigerated and protected from light. See our storage guide for handling detail.
